Castle Biosciences, Inc. Stock
Equities
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.53 USD | +0.66% | -1.57% | +13.67% |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 261M | Capitalization | 677M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -56M | EV / Sales 2024 * | 1.64 x |
Net cash position 2024 * | 249M | Net cash position 2025 * | 201M | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
-15.1
x | P/E ratio 2025 * |
-12.9
x | Employees | 638 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.98% |
Latest transcript on Castle Biosciences, Inc.
1 day | +0.66% | ||
1 week | -1.57% | ||
Current month | +16.31% | ||
1 month | +20.60% | ||
3 months | +0.57% | ||
6 months | +25.92% | ||
Current year | +13.67% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Franklin Stokes
DFI | Director of Finance/CFO | 54 | 17-11-30 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Daniel Bradbury
CHM | Chairman | 62 | 12-08-31 |
G. Cole
BRD | Director/Board Member | 68 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 11 M€ | -6.03% | - | |
0.60% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 234 M€ | +11.93% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 24.53 | +0.66% | 179,661 |
24-05-24 | 24.37 | +2.65% | 130,508 |
24-05-23 | 23.74 | -3.02% | 287,263 |
24-05-22 | 24.48 | -1.77% | 217,120 |
24-05-21 | 24.92 | -0.08% | 216,001 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.67% | 677M | |
-6.41% | 12.1B | |
-4.07% | 8.14B | |
+5.77% | 5.72B | |
+28.13% | 5.51B | |
-59.44% | 2.72B | |
+8.04% | 2.59B | |
-6.47% | 2.34B | |
+21.84% | 2.11B | |
-8.15% | 1.79B |
- Stock Market
- Equities
- CSTL Stock